Randomized Single Institution Pilot Study of Vaccinia-CEA(6D)-TRICOM and Fowlpox-CEA(6D)-TRICOM With GM-CSF in Combination With Docetaxel in Patients With CEA-Bearing Cancers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Rilimogene glafolivec; Sargramostim; Vaccinia CEA
- Indications Colorectal cancer; Lung cancer
- Focus Therapeutic Use
- 31 Mar 2014 Biomarkers information updated
- 23 Jun 2009 Additional lead trial centre (National Cancer Institute), lead trial investigator (Marshall JL) added as reported by ClinicalTrials.gov
- 23 Jun 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.